Sichuan Biokin A/H Listing: Milestone Payment and New Clinical Data
Sichuan Biokin aims to raise $500 million through A-H listing with backing from GS, JPM, and CITIC. Recent development for the company is mostly...
367 Views
CSI 300 Index Earning Revision (Jul): Wuxi Apptec, Eoptolink Technology, Ping An Insurance
We analyzed CSI 300's consensus for Jul 2025 and highlighted changes of EPS in Wuxi Apptec, Eoptolink Technology, Ping An Insurance, Muyuan Foods,...
505 Views
STAR50 Index Earning Revision (Jul): Xinjiang Daqo, Hwatsing Technology, Jinko Solar, Transsion
We analyzed STAR50's consensus for Jul 2025 and highlighted changes of EPS in Xinjiang Daqo, Hwatsing Technology, Jinko Solar, Transsion, Montage...
1.2k Views
STAR50 Index Earning Revision (Jun): Bestechnic, Csi Solar, Biwin Storage Technology
We analyzed STAR50's consensus for Jun 2025 and highlighted changes of EPS in Bestechnic (Shanghai), Csi Solar, Biwin Storage Technology,...
469 Views
China Healthcare Weekly (Jun.1)-Akeso/Summit's Disappointing Ph3 Readout,Valuation Outlook of Biokin
CR Sanjiu plans to transfer 49.8967% equity of Sanjiu (Anguo).Summit/Akeso's disappointing phase 3 readout raises doubts on FDA approval for...
513 Views